Scientists develop first-of-its-kind antibody to block Epstein Barr virus
On Feb. 17, 2026, Fred Hutch Cancer Center scientists announced reaching a crucial milestone in blocking Epstein Barr…
-
-
Biotechnology | FDA | Oncology
FDA Grants Full Approval of First Oral Treatment for Lymphoma in Dogs
On Jan. 16, 2026, the U.S. Food and Drug Administration (FDA) announced it had granted full approval of…
-
Biotechnology | FDA | Oncology
FDA conditionally approved first oral tablet to treat lymphoma in dogs
On Jan. 11, 2021, the U.S. Food and Drug Administration (FDA) conditionally announced it had approved Anivive Lifesciences’…
-
Biotechnology | HIV | NIH | Oncology
Study confirmed effective, less toxic alternative to standard treatment for adults with Burkitt lymphoma
On May 26, 2020, the National Institutes of Health (NIH) announced a new study that provides an alternative…
-
A virus (the Epstein-Barr virus) was linked to human cancer (Burkitt lymphoma) for the first time
In 1964, a new herpesvirus, Epstein-Barr virus (EBV), was discovered in cultured tumor cells derived from a Burkitt…
